Indication
portal hypertension
13 clinical trials
15 products
3 drugs
Product
Methacetin Breath TestClinical trial
Companion Protocol for the ¹³C-Methacetin Breath Test Using the BreathID® MCS System for Conatus Phase 2 Study of Emricasan, an Oral Caspase Inhibitor, Under Protocol IDN-6556-14 (NCT02960204)Status: Completed, Estimated PCD: 2019-04-08
Product
PlaceboProduct
EmricasanClinical trial
Continuous Versus Bolus Infusion of Terlipressin for Portal Hypertension Related Bleeding in Liver Cirrhosis: A Prospective Non-randomized Controlled TrialStatus: Not yet recruiting, Estimated PCD: 2025-12-01
Product
TerlipressinClinical trial
Technical Development and Clinical Validation of a Comprehensive One-stop Shop Assessment of the Cirrhotic Liver With [68Ga]Ga-PSMA-11 PET/MRIStatus: Recruiting, Estimated PCD: 2026-12-19
Product
Gadolinium contrast agentProduct
RadiotracerClinical trial
NEPH-ROSIS (NEPHrology in CirRhOSIS) Pilot Trial: A Trial to Treat Acute Kidney Injury Among Hospitalized Cirrhosis PatientsStatus: Recruiting, Estimated PCD: 2024-05-01
Product
MAP-Target AlgorithmClinical trial
LiveSMART: A Sequential, Multiple Assignment Randomized Trial to Prevent Falls in Patients With CirrhosisStatus: Recruiting, Estimated PCD: 2025-05-01
Product
LactuloseClinical trial
Acute Hemodynamic Response to Carvedilol in Children With Clinically Significant Portal Hypertension.Status: Recruiting, Estimated PCD: 2025-02-14
Product
CarvedilolClinical trial
Zinc Supplementation to Improve Prognosis in Patients With Compensated Advanced Chronic Liver Disease: A Multicenter, Randomized, Double-blind, Placebo Controlled Clinical TrialStatus: Recruiting, Estimated PCD: 2026-03-02
Product
Zinc AcexamateClinical trial
Efficacy of Carvedilol + Ivabradine vs Carvedilol Alone for Left Ventricular Diastolic Dysfunction in Chronic Liver Disease Patients and Its' Impact on Morbidity and Mortality; a Prospective Randomized Controlled Trial.Status: Recruiting, Estimated PCD: 2024-10-01
Product
Betablocker + IvabradineProduct
BetablockerClinical trial
Noninvasive Subharmonic Aided Pressure Estimation of Portal HypertensionStatus: Recruiting, Estimated PCD: 2026-02-28
Product
SHAPE measurementClinical trial
Beta-blockers Or Placebo for Primary Prophylaxis of Oesophageal Varices (BOPPP Trial). A Blinded, UK Multi-centre, Clinical Effectiveness and Cost-effectiveness Randomised Controlled Trial.Status: Recruiting, Estimated PCD: 2026-12-01
Drug
VarlilumabClinical trial
Improvement of Portal Hypertension During Viral Suppression in Patients With Hepatitis Delta (IMPHROVE-D)Status: Recruiting, Estimated PCD: 2024-10-31
Product
BulevirtideClinical trial
Impact of Fentanyl Analgesia on the Accuracy of Hepatic Venous Pressure Gradient Measurements in Patients With Portal Hypertension：a Prospective, Multicenter StudyStatus: Recruiting, Estimated PCD: 2024-11-01
Drug
KetamineClinical trial
Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver TransplantStatus: Recruiting, Estimated PCD: 2025-12-07
Drug
AN0025Product
Tremelimumab